To develop a valid statistical method of showing acceptable cardiac output (CO) trending ability when new CO monitors are compared to a reference standard, such as thermodilution, using polar coordinates.
With regard to exposure assessment method, meta-estimates from studies using fixed site monitors were compared to those from studies using modeling-based estimation techniques, for example, land use regression.
Awake patient monitoring was compared with the three TCD criteria.
The INVOS monitoring was compared with sensory deficits, pain, motor activity, electromyography and invasive pressure.
When the small survival benefit associated with monitoring was compared between two cumulative Dox doses, the survival benefit conferred by MUGA scanning was twice as high for the 500 mg m−2 group as for the 350 mg m−2 group.
The relation between serum metformin levels and other variables was assessed using linear regression analysis and expressed as R. Severity of illness at admission of patients with or without CI monitoring was compared using the Student's t-test.
This noninvasive method of CO monitoring was compared in several studies to thermodilution using a pulmonary artery catheter documenting good correlation (R = 0.82) and minimal bias (± 4%) (11) and a three times faster response rate.
When an initial two step approach with a random effects model was used, the overall estimated reduction in HbA1c was 0.30%95%5% confidence interval −0.43% to −0.17%) (3.0, −4.3 to −1.7 mmol/mol) when continuous glucose monitoring was compared with self monitoring of blood glucose (fig 2).
Each hour glucose value from continuous glucose monitor was compared to reference arterial glucose using the Clarke error-grid analysis (C-EGA) [ 15] and when clinically unacceptable (zone C, D, or E of C-EGA) reference glycemia was used as input for the eMPC and to recalibrate the Guardian REAL-Time.
Different strategies of monitoring are compared based on the tracking the qualitative transformation of the bar׳s vibration.
